Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05856539 · ClinicalTrials.gov registry record · NA
ESP Block in MIS Lumbar Spine Surgery
A NA study of Patients With Spinal Stenosis Indicated for MIS TLIF, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05856539: Recruiting NA study of Patients With Spinal Stenosis Indicated for MIS TLIF, sponsored by Hospital for Special Surgery, New York.
NCT05856539 is a NA study of Patients With Spinal Stenosis Indicated for MIS TLIF that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05856539, a NA study of Patients With Spinal Stenosis Indicated for MIS TLIF, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
Primary Outcome
The primary outcome of the study will be cumulative opioid use in the first 24 hours postoperatively in oral morphine milligram equivalents (OMEs) (24 hour period from PACU admission to POD1).
Conditions Studied
Interventions
- PROCEDURE Erector spinae plane (ESP) block
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2026-07-15 |
| Phase | NA |
What NCT05856539 shows while recruiting
NCT05856539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Patients With Spinal Stenosis Indicated for MIS TLIF appearing as the primary indexed condition, and to 1 intervention - of which Erector spinae plane (ESP) block is the first listed.
NCT05856539 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05856539 about?
NCT05856539 is a clinical study titled "ESP Block in MIS Lumbar Spine Surgery". This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
What is the current status of trial NCT05856539?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-15. Estimated completion is 2026-07-15.
What conditions does trial NCT05856539 study?
This clinical trial studies the following conditions: Patients With Spinal Stenosis Indicated for MIS TLIF.
What interventions are being tested in trial NCT05856539?
The interventions under investigation include: Erector spinae plane (ESP) block (PROCEDURE).
Who is sponsoring clinical trial NCT05856539?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05856539 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05856539's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI